Hangzhou KBM Life sciences Co.,Ltd. was established in September 2012. With precision drug genetic testing as its strategic direction, it is a high-end biomedical product manufacturer dedicated to precision medicine, genetic testing, and biological scientific research services. As a national high-tech enterprise, the company has established a series of genetic testing methods, has independent intellectual property rights, and has researched and developed a full range of molecular diagnostic products for individualized drugs for cardiovascular and cerebrovascular diseases. At the same time, the company has built a first-class R&D center and GMP standard industrialization workshop, passed the ISO13485:2016 international standard quality system certification, and 7 products including the human ACE genotyping test kit have passed the European Union (CE) certification. Baimai Biology takes innovation and R&D as its mission, and has applied for more than 30 patents and obtained 17 patent authorizations. There are more than 50 R&D, quality, and registration teams, many of whom have work experience in well-known companies in the industry. The company's products will gradually enter various large and medium-sized hospitals and third-party inspection laboratories across the country.
Founded in 2012, Hangzhou KBM Life sciences Co.,Ltd. is a high-tech enterprise in Hangzhou. It is a high-end biomedical product manufacturer dedicated to precision medicine, genetic testing, and biological scientific research services. The company has built a corporate culture of "customer service as the guide, diagnosis, guidance and treatment as the core, forge ahead, and the courage to innovate", so that all products and services integrate technology, innovation, and harmony. The field takes the lead in the industry.
The company has a first-class R&D center and a 100,000-level clean workshop (the core area is 10,000-level), and has passed the ISO9001: 2008 quality management system standard. It has a complete and independent R&D system, strong R&D capabilities, and has obtained 14 national authorized patents. It has successfully developed dozens of internationally advanced magnetic bead nucleic acid extraction kits, including saliva, whole blood, and plasma , Animals, plants, viruses and other nucleic acid extraction kits. Many of these products have obtained medical device product certificates issued by the China Food and Drug Administration.
The company focuses on the research and development of diagnostic kit products that can be used for precision medicine and personalized medicine guidance. It has now cooperated with Zhejiang University Cancer Institute to establish an "industry-university-research" incubation center, equipped with Illumina high-throughput second-generation sequencing equipment platform, Conduct joint research on clinical molecular diagnostic markers, and actively develop precision medical diagnostic kits suitable for clinical use.
At the same time, the company has built a GMP III production plant and a KBM medical laboratory, actively promoting the development of a "production + service" genetic testing clinical terminal service system, and directly providing primary and secondary genetic testing for primary and secondary medical institutions in Zhejiang and even the country. Technical clinical diagnostic testing services.